Jama derm - This phase 2b, placebo-controlled, randomized clinical trial evaluates the efficacy and safety of lebrikizumab, a novel, high-affinity, monoclonal antibody targeting interleukin (IL)–13 that selectively prevents formation of the IL-13Rα1/IL-4Rα heterodimer receptor signaling complex, in adults with...

 
JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …. Rooter rooter

This association was stronger among those studies conducted for dermatologic indications as well as among JAK1-specific, combined JAK1 and JAK2, and tyrosine kinase 2–specific inhibitor treatments. Meaning These findings suggest that patients should be properly counseled on the potential adverse effect of acne before beginning treatment with ... Dr Shields is Assistant Section Editor of JAMA Dermatology, but she was not involved in any of the decisions regarding review of the manuscript or its acceptance. Meeting Presentation: This paper was presented at the 2022 Meeting of the American Academy of Dermatology; March 25, 2022; Boston, Massachusetts. Additional Contributions: We …Generalized pruritus is a distressing symptom that can occur in several dermatologic and systemic disorders. 1 Generalized pruritus of unknown origin is that which affects patients without any underlying dermatologic or systemic disorder and is unassociated with rash. It most commonly occurs in older patients and persists for long periods, from months to years.Aug 1, 2022 · Design, Setting, and ParticipantsThis was a multicenter, vehicle-controlled, double-blind, phase 3 randomized clinical trial (B-SIMPLE4) conducted in 55 clinics (mostly dermatology and pediatric) in the US from September 1, 2020, to July 21, 2021. From a policy perspective, it is hard to understand the Modi government’s approach towards education. Sarwari Jahan is an Accredited Social Health Activist in her early 30s who wor...Histopathology revealed psoriasiform epidermal hyperplasia with confluent parakeratosis and epidermal pallor consistent with acrodermatitis enteropathica (AE). Oral zinc supplementation was initiated at a dose of 3 mg/kg, with rapid improvement. This case report describes a woman in her 20s with painful, red skin lesions present for 6 months ... JAMA Dermatology’s mission is to elevate the art and science of health and diseases of skin, hair, nails, and mucous membranes, and their treatment, to enable dermatologists to deliver evidence-based, high-value medical and surgical dermatologic care. JAMA Network is a consortium of peer-reviewed medical publications that includes JAMA® and the JAMA Network journals. JAMA Dermatology does not hold itself responsible for statements made by any contributor. All articles published, including opinion articles, represent the views of the authors and do not reflect the policy of the Journal, the ... JAMA Dermatology Clinicopathological Challenge . October 12, 2022. Numerous Angiomatous Lesions in an Infant. Catherine Reilly, BS 1; Nidhi Shah, MD 2; Kaiane Habeshian, MD 3. Author Affiliations Article Information. 1 Georgetown University School of Medicine, Washington, DC. 2 George Washington University School of Medicine and …Hidradenitis suppurativa (HS) is relatively common, with the prevalence of 0.05% to 4.10%, yet many patients receive inadequate treatment. To review the diagnosis, epidemiology, and treatment of HS with an emphasis on advances in the last 5 years. A literature search was conducted using PubMed, MEDLINE (Medical Subject Headings …JAMA Dermatology. Full Text. Basal cell carcinoma (BCC) is estimated to be the most common cancer and primarily occurs in light-skinned, older patients. While accurate mortality rates are difficulty to calculate, they are estimated to be low (on the order of 0.12 per 100 000). 1 For the vast majority of patients, BCC has an indolent course and an …JAMA Network is a consortium of peer-reviewed medical publications that includes JAMA® and the JAMA Network journals. JAMA Dermatology does not hold itself responsible for statements made by any contributor. All articles published, including opinion articles, represent the views of the authors and do not reflect the policy of the Journal, the …The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology suggests that you consult your ... JAMA Dermatology. Neuropathic itch refers to disorders characterized by chronic itching caused by dysfunction or damage to pruriceptors, nerves involved in itch transmission. In these conditions, itch is not triggered by external stimuli (eg, irritants or allergens), but rather arises spontaneously. Neuropathic itch can occur through nerve damage from …JAMA Dermatology. Key Points. Question What is the contemporary prevalence and incidence of alopecia areata (AA), alopecia totalis, and alopecia universalis in the US? Findings In this cohort study of a nationwide US employer-sponsored insurance population, AA prevalence was 0.199% to 0.222%, and AA incidence was 91.46 to 92.90 cases per …JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …A, Week 8 represents the patient outcomes of cycle 1 with hypericin PDT (n = 116) or placebo (n = 50) for 6 wks plus a 2-wk rest period before evaluation; week 16, outcomes for patients who received hypericin PDT in cycle 1 and for 6 wks in cycle 2 (n = 44 of 110) plus another 2-wk rest; and week 24, outcomes for patients who received hypericin PDT in cycles 1 and 2 and continued with optional ... Disclaimer: Dr Barbieri is the CME/Clinical Review and Education Editor of JAMA Dermatology but was not involved in any of the decisions regarding review of the manuscript or its acceptance. References 1. Lainscak M , Pelliccia F , Rosano G , et al. Safety profile of mineralocorticoid receptor antagonists: spironolactone and eplerenone. …Key Points. Question What are the fertility rates and birth outcomes in female patients with psoriasis when compared with age- and practice-matched patients without psoriasis?. Findings This cohort study included 63 681 patients with psoriasis and 318 405 matched comparators of common reproductive ages from the UK Clinical Practice Research …The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology suggests that you consult your ... Kanade Shinkai, MD, PhD, Department of Dermatology, University of Calfornia, San Francisco, 1701 Divisadero St, San Francisco, CA 94115 ( [email protected]. In this Viewpoint, JAMA Dermatology editors review the skin findings seen in association with coronavirus disease 2019 (COVID-19), how best to …10.1001/jamadermatol.2020.4616 While current evidence supports UV exposure as an important risk factor for cutaneous melanoma in fair-skinned populations, the evidence …This living systematic review and network meta-analysis examines the association of systemic treatments for atopic dermatitis with scores on the Eczema Area and Severity Index, Patient Oriented Eczema Measure, Dermatology Life Quality Index, and Peak Pruritus Numeric Rating Scales. Case reports of ulcerative PG and mimickers were collected through a PubMed search for cases published in respected peer-reviewed medical journals chosen by impact factor (Journal of the American Academy of Dermatology, JAMA Dermatology, British Journal of Dermatology, Journal of the European Academy of Dermatology and Venereology, and …Basal and squamous cell carcinomas are the most common types of skin cancer but infrequently lead to death or substantial morbidity. Melanomas represent about 1% of skin cancer and cause the most skin cancer deaths. Melanoma is about 30 times more common in White persons than in Black persons.Medicine Matters Sharing successes, challenges and daily happenings in the Department of Medicine ARTICLE: Factors Associated With Overuse of Health Care Within US Health System AU...Key Points. Question What are the fertility rates and birth outcomes in female patients with psoriasis when compared with age- and practice-matched patients without psoriasis?. Findings This cohort study included 63 681 patients with psoriasis and 318 405 matched comparators of common reproductive ages from the UK Clinical Practice Research …JAMA Dermatology Clinicopathological Challenge Arc-Shaped Furrow on the Forehead Extending From Linear Alopecia on the Vertex Il-Jae Lee, MD; Seok-Kweon Yun, MD, PhD; Kyung-Hwa Nam, MD, PhD 10 May 2023 ... JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA ... Acta Derm Venereol. 2016;96(2):157 ...Looking for the perfect acne treatment that works for your type of acne *and* your skin type? Check out our derm-approved picks for the best acne treatments. We include products we...Jan 7, 2013 · JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Aug 31, 2021 · We read with great interest the article of Blauvelt et al investigating the safety and efficacy of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis (AD).1 We do agree with the author that upadacitanib have revealed a superiority over dupilumab in term of efficacy and safety. In this issue of JAMA Dermatology, Boesjes et al 1 share their experience with patients with presumed atopic dermatitis (AD) who, shortly after dupilumab initiation, experienced worsening skin symptoms unlike their previous disease. Skin biopsies were characterized by atypical T-cell lymphocytic infiltrates. Although some of these patients developed …JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JAMA Dermatology. Key Points. Question What is the short-term and long-term comparative efficacy among biologics and oral agents for plaque psoriasis? Findings In a network meta-analysis of 60 clinical …Key Points. Question What were the treatment patterns for alopecia areata (AA) in adults in the US from 2015 to 2020?. Findings In this cohort study of 45 483 adults with AA, on the basis of US medical and pharmacy claims data, most common treatments for AA included intralesional, topical, intramuscular, and oral corticosteroids. JAMA Dermatology. Full Text. Key Points. Question What were the outcomes for patients with clinically and histologically confirmed Hailey-Hailey disease who were treated with superficial radiotherapy? Findings In this case series of 13 patients with Hailey-Hailey disease, 56 of 62 separate body areas (90%) and 9 of 13 patients (69%) responded with …Key Points. Question What is the risk of developing inflammatory bowel disease in children and adults with atopic dermatitis (AD)?. Finding This population-based cohort study of …Importance Rituximab has emerged as a front-line therapy for pemphigus, but prognostic factors for achieving complete remission off therapy (CROT) with oral systemic agents remain unknown.. Objectives To describe rates of CROT and relapse and identify prognostic factors for achieving CROT after rituximab therapy for pemphigus.. Design, Setting, and …The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology suggests that you consult your ... JAMA Dermatology. Abstract Importance Oral isotretinoin has been associated with several adverse effects, but evidence-based estimates of laboratory changes during isotretinoin therapy in large patient samples are limited. Objective To develop estimates of the laboratory changes that occur during isotretinoin therapy for acne using extant data …JAMA Dermatology. Key Points. Question What is the contemporary prevalence and incidence of alopecia areata (AA), alopecia totalis, and alopecia universalis in the US? Findings In this cohort study of a nationwide US employer-sponsored insurance population, AA prevalence was 0.199% to 0.222%, and AA incidence was 91.46 to 92.90 cases per …JAMA Dermatology. Key Points. Question What is the diagnostic accuracy of clinical examination and baseline ultrasonography for the detection of regional lymph node metastasis in patients with high-risk cutaneous squamous cell carcinoma (SCC) of the head and neck, and what is the diagnostic accuracy of ultrasonography among patients with …Traditional Chinese Medicine (TCM) aims to promote health by bringing the body’s systems into balance. Learn how this ancient approach can be a helpful part of eczema management. P...Aug 1, 2022 · Design, Setting, and ParticipantsThis was a multicenter, vehicle-controlled, double-blind, phase 3 randomized clinical trial (B-SIMPLE4) conducted in 55 clinics (mostly dermatology and pediatric) in the US from September 1, 2020, to July 21, 2021. Interviews with authors of articles from JAMA Dermatology. JAMA Dermatology covers research on the skin, its diseases, and their treatment.JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …A, Measure Up 1. B, Measure Up 2. C, AD Up. Nominal P values are calculated using Cochran-Mantel-Haenszel test with the adjustment of baseline vIGA-AD categories (3; 4). ). Based on nonresponder imputation incorporating multiple imputation to handle missing data due to COVID-19 or nonresponder imputation only if there were no missing data due to COVI In individual patients, the risks and benefits of WW and treatment can be weighed using this algorithm. The frequency of follow-up visits (eg, every 3-6 months) should be based on the feasibility for individual cases and can be adjusted (preferably by visiting a dermatology outpatient clinic when feasible; if not possible, eg, follow-up through teledermatology or general practitioner) when ... Explore health information written for patients from JAMA Dermatology’s editors, including easy-to-understand explanations of atopic dermatitis, psoriasis, and more. Add to My …Importance Determining psoriasis prevalence is fundamental to understanding the burden of the disease, the populations most affected, and health policies to address the disease.. Objective (1) To determine the prevalence of psoriasis among adults in the US and (2) to evaluate the change in psoriasis prevalence over time since the 2003-2004 National …JAMA Dermatology. Audio (19:02) A Skin-Directed Scoring System for Epidermal Necrolysis. 1x. 0:00 / 0:00. Subscribe to Podcast. Full Text. Key Points. Question Is there a need for an EN skin-directed scoring system, consistent EN terminology, a better understanding of orphologic progression, and/or identification of the most-affected sites? ...JAMA Dermatology Hyperpigmentation is a common cutaneous concern in individuals with skin of color, 1 often leading to psychosocial distress. 2 Given the lack of rigorous clinical …Case reports of ulcerative PG and mimickers were collected through a PubMed search for cases published in respected peer-reviewed medical journals chosen by impact factor (Journal of the American Academy of Dermatology, JAMA Dermatology, British Journal of Dermatology, Journal of the European Academy of Dermatology and Venereology, and …JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …The most common dermatologic treatment during a flare episode was topical corticosteroids (35% of flare episodes [178 of 513]) followed by other oral dermatologic treatments (eg, methotrexate, cyclosporine, tacrolimus; 13% [67 of 513]), and oral corticosteroids (11% [54 of 513]) . Opioids were prescribed during 21% of flare episodes …5 Jul 2023 ... JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology ...Key Points. Question What is the efficacy and safety of once-daily roflumilast foam, 0.3%, in adult patients with seborrheic dermatitis?. Findings In this randomized clinical trial that included 226 patients with seborrheic dermatitis, 73.8% of roflumilast-treated patients achieved Investigator Global Assessment success at week 8 compared with 40.9% in the vehicle group, a statistically ... Feb 14, 2024 · Systemic Immunomodulatory Treatments for Atopic Dermatitis. Explore the latest treatments for vitiligo, hidradenitis suppurativa, lichen sclerosus, melanoma, …A, Week 8 represents the patient outcomes of cycle 1 with hypericin PDT (n = 116) or placebo (n = 50) for 6 wks plus a 2-wk rest period before evaluation; week 16, outcomes for patients who received hypericin PDT in cycle 1 and for 6 wks in cycle 2 (n = 44 of 110) plus another 2-wk rest; and week 24, outcomes for patients who received hypericin PDT in cycles 1 and 2 and continued with optional ... 6 Jul 2022 ... JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA ... Acta Derm Venereol. 2020;100(19): ...JAMA Dermatology. Key Points. Question What are the safety, efficacy, and biomarker responses of dupilumab treatment in patients with erythrodermic atopic dermatitis (AD)? Findings In this post hoc analysis of 209 patients with erythrodermic AD in 6 randomized, placebo-controlled clinical trials, dupilumab treatment (either as …From a policy perspective, it is hard to understand the Modi government’s approach towards education. Sarwari Jahan is an Accredited Social Health Activist in her early 30s who wor...Disclaimer: Dr Adamson is an Associate Editor and Web Editor of JAMA Dermatology, but he was not involved in any of the decisions regarding review of the manuscript or its acceptance. References: 1. Chen ST , Geller AC , Tsao H . Update on the epidemiology of melanoma. Curr Dermatol Rep. 2013;2(1):24-34. doi:10.1007/s13671 ...JAMA Dermatology Hyperpigmentation is a common cutaneous concern in individuals with skin of color, 1 often leading to psychosocial distress. 2 Given the lack of rigorous clinical …JAMA Dermatology. Abstract Importance Oral isotretinoin has been associated with several adverse effects, but evidence-based estimates of laboratory changes during isotretinoin therapy in large patient samples are limited. Objective To develop estimates of the laboratory changes that occur during isotretinoin therapy for acne using extant data …In dermatology practice, patients frequently present with a recalcitrant eruption distinguished by the presence of edematous, urticarial, intensely pruritic papules. After analysis of patient biopsy specimens, the dermatopathologist will often report a “dermal hypersensitivity reaction” (DHR) characterized by an eosinophil-rich infiltrate.Importance Knowledge regarding differences in dermatologic care for patients with a broad range of dermatologic conditions is limited.. Objective To elucidate nationwide differences in use of outpatient dermatologic care.. Design, Setting, and Participants Retrospective analysis of nationally representative data from the 2007 to 2015 Medical Expenditure …JAMA Dermatology. Key Points. Question Can 2-photon fluorescence microscopy enable rapid point-of-care diagnosis of nonmelanoma skin cancer through real-time imaging of unprocessed fresh tissue biopsies? Findings In this pilot comparative effectiveness research study using 2-photon fluorescence microscopy on 15 biopsies of known non-melanoma …JAMA Dermatology Patient Page. Measles. Bharath Balu, PhD; Eliot N. Mostow, MD, MPH. JAMA Dermatology. Measles (rubeola) is an infection caused by a highly contagious virus primarily spread by respiratory droplets. How Common Is Measles and How Contagious Is It? Measles is currently rare in the US because highly effective vaccines …Jan 24, 2024 · The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology suggests that you consult your ... In dermatology practice, patients frequently present with a recalcitrant eruption distinguished by the presence of edematous, urticarial, intensely pruritic papules. After analysis of patient biopsy specimens, the dermatopathologist will often report a “dermal hypersensitivity reaction” (DHR) characterized by an eosinophil-rich infiltrate.JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …Jan 7, 2013 · JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology suggests that you consult your …19 Jan 2022 ... Cardiovascular disease is a leading cause of this excess mortality and guidelines from the American Academy of Dermatology/National Psoriasis ...Dec 1, 2018 · Little evidence exists to guide the management of moderately dysplastic nevi excisionally biopsied without residual clinical pigmentation but with positive histologic margins (hereafter referred to as moderately dysplastic nevi with positive histologic margins). To determine outcomes and risk for the development of subsequent cutaneous melanoma ... JAMA Dermatology. Full Text. Basal cell carcinoma (BCC) is estimated to be the most common cancer and primarily occurs in light-skinned, older patients. While accurate mortality rates are difficulty to calculate, they are estimated to be low (on the order of 0.12 per 100 000). 1 For the vast majority of patients, BCC has an indolent course and an …Omega-3s were supposed to protect us all from heart disease and other health problems, but it’s taken some time for the evidence to catch up with the hype around these supplements....JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Kanade Shinkai, MD, PhD, Department of Dermatology, University of Calfornia, San Francisco, 1701 Divisadero St, San Francisco, CA 94115 ( [email protected]. In this Viewpoint, JAMA Dermatology editors review the skin findings seen in association with coronavirus disease 2019 (COVID-19), how best to …Kanade Shinkai, MD, PhD, Department of Dermatology, University of Calfornia, San Francisco, 1701 Divisadero St, San Francisco, CA 94115 ( [email protected]. In this Viewpoint, JAMA Dermatology editors review the skin findings seen in association with coronavirus disease 2019 (COVID-19), how best to respond to those. 6 Jul 2022 ... JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA ... Acta Derm Venereol. 2020;100(19): ...Dermatology image-based AI algorithms must consider the unique features of dermatology data, which currently include a lack of standardization among imaging modalities and the risk of bias from noisy labels or demographically unrepresentative data. 2,14-16 These guidelines are intended as requirements for the consideration of study …JAMA Network is a consortium of peer-reviewed medical publications that includes JAMA® and the JAMA Network journals. JAMA Dermatology does not hold itself responsible for statements made by any contributor. All articles published, including opinion articles, represent the views of the authors and do not reflect the policy of the Journal, the …JAMA Dermatology. Hyperpigmentation is a common cutaneous concern in individuals with skin of color, 1 often leading to psychosocial distress. 2 Given the lack of rigorous clinical studies, expert opinion guides accepted treatment algorithms. Acquired facial hyperpigmentation commonly presents as melasma or postinflammatory …Key Points. Question What are the characteristics of patients older than age 85 years with nonmelanoma skin cancer receiving Mohs surgery?. Findings In this cohort study of 1181 patients older than age 85 years referred for Mohs surgery, those treated with Mohs surgery were more likely to have facial tumors and high functional status than those not treated …JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …Contact Us | JAMA Dermatology | JAMA Network Contact Us Customer Service Technical Support Editorial JAMA Network Media Relations Advertising Reprints ...Corresponding Author: Ruth Ann Vleugels, MD, Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115 ([email protected]). Author Contributions: Dr Vleugels had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of …The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology suggests that you consult your …

In dermatology practice, patients frequently present with a recalcitrant eruption distinguished by the presence of edematous, urticarial, intensely pruritic papules. After analysis of patient biopsy specimens, the dermatopathologist will often report a “dermal hypersensitivity reaction” (DHR) characterized by an eosinophil-rich infiltrate.. Att shop

jama derm

Key Points. Question What were the treatment patterns for alopecia areata (AA) in adults in the US from 2015 to 2020?. Findings In this cohort study of 45 483 adults with AA, on the basis of US medical and pharmacy claims data, most common treatments for AA included intralesional, topical, intramuscular, and oral corticosteroids. Jan 7, 2013 · JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Archives of Dermatology Reader's Choice: Continuing Medical Education · Citation · We recommend · JAMA Dermatology · JAMA Network · Help.JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …JAMA Dermatology. Key Points. Questions What is the drug survival of adalimumab, ustekinumab, secukinumab, guselkumab, ixekizumab that is associated with effectiveness and safety in patients with psoriasis in the UK and Ireland, and are there any patient factors that are associated with survival of each biologic differently that could help treatment …JAMA Dermatology. Key Points. Question What is the short-term and long-term comparative efficacy among biologics and oral agents for plaque psoriasis? Findings In a network meta-analysis of 60 clinical …30 Aug 2023 ... JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology ...JAMA Dermatology. Key Points. Question What is the efficacy and safety of bimekizumab in individuals with moderate to severe hidradenitis suppurativa (HS)? Findings In this double-blind, placebo-controlled, phase 2 randomized clinical trial including 90 randomized patients with HS (73 completed the trial), bimekizumab demonstrated clinically …Contact Us | JAMA Dermatology | JAMA Network Contact Us Customer Service Technical Support Editorial JAMA Network Media Relations Advertising Reprints ...The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology suggests that you consult your …JAMA Dermatology. Full Text. Basal cell carcinoma (BCC) is estimated to be the most common cancer and primarily occurs in light-skinned, older patients. While accurate mortality rates are difficulty to calculate, they are estimated to be low (on the order of 0.12 per 100 000). 1 For the vast majority of patients, BCC has an indolent course and an …JAMA Dermatology. Key Points. Question Can tape strips serve as a minimally invasive approach to assess biomarkers for early-onset pediatric atopic dermatitis? Findings In this cross-sectional study of 51 children younger than 5 years with and without atopic dermatitis, the use of tape strips, a minimally invasive approach for …JAMA Dermatology’s mission is to elevate the art and science of health and diseases of skin, hair, nails, and mucous membranes, and their treatment, to enable dermatologists …JAMA Dermatology. Key Points. Question What is the diagnostic accuracy of clinical examination and baseline ultrasonography for the detection of regional lymph node metastasis in patients with high-risk cutaneous squamous cell carcinoma (SCC) of the head and neck, and what is the diagnostic accuracy of ultrasonography among patients with …In dermatology practice, patients frequently present with a recalcitrant eruption distinguished by the presence of edematous, urticarial, intensely pruritic papules. After analysis of patient biopsy specimens, the dermatopathologist will often report a “dermal hypersensitivity reaction” (DHR) characterized by an eosinophil-rich infiltrate.JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …Key Points. Question What were the treatment patterns for alopecia areata (AA) in adults in the US from 2015 to 2020?. Findings In this cohort study of 45 483 adults with AA, on the basis of US medical and pharmacy claims data, most common treatments for AA included intralesional, topical, intramuscular, and oral corticosteroids. Key Points. Question What is the current point prevalence of vitiligo among adults in the US?. Findings This cross-sectional, population-based online survey study of more than 40 000 adults in the US was conducted between December 2019 and March 2020. Participant self-report, and adjudication of vitiligo by 3 dermatologists through participant submission ….

Popular Topics